196 related articles for article (PubMed ID: 37511317)
1. Pro-Tumor Activity of Endogenous Nitric Oxide in Anti-Tumor Photodynamic Therapy: Recently Recognized Bystander Effects.
Girotti AW; Bazak J; Korytowski W
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511317
[TBL] [Abstract][Full Text] [Related]
2. Bystander Effects of Nitric Oxide in Cellular Models of Anti-Tumor Photodynamic Therapy.
Bazak J; Korytowski W; Girotti AW
Cancers (Basel); 2019 Oct; 11(11):. PubMed ID: 31661869
[TBL] [Abstract][Full Text] [Related]
3. Enhanced aggressiveness of bystander cells in an anti-tumor photodynamic therapy model: Role of nitric oxide produced by targeted cells.
Bazak J; Fahey JM; Wawak K; Korytowski W; Girotti AW
Free Radic Biol Med; 2017 Jan; 102():111-121. PubMed ID: 27884704
[TBL] [Abstract][Full Text] [Related]
4. Multiple Means by Which Nitric Oxide can Antagonize Photodynamic Therapy.
Girotti AW; Fahey JM; Korytowski W
Curr Med Chem; 2016; 23(24):2754-2769. PubMed ID: 27776475
[TBL] [Abstract][Full Text] [Related]
5. Nitric Oxide-Mediated Resistance to Antitumor Photodynamic Therapy.
Girotti AW
Photochem Photobiol; 2020 May; 96(3):500-505. PubMed ID: 31545517
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide-mediated resistance to photodynamic therapy in a human breast tumor xenograft model: Improved outcome with NOS2 inhibitors.
Fahey JM; Girotti AW
Nitric Oxide; 2017 Jan; 62():52-61. PubMed ID: 28007662
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of nitric oxide in tumor cells as a negative adaptation to photodynamic therapy.
Girotti AW
Lasers Surg Med; 2018 Jul; 50(5):590-598. PubMed ID: 29504635
[TBL] [Abstract][Full Text] [Related]
8. Accelerated migration and invasion of prostate cancer cells after a photodynamic therapy-like challenge: Role of nitric oxide.
Fahey JM; Girotti AW
Nitric Oxide; 2015 Sep; 49():47-55. PubMed ID: 26068242
[TBL] [Abstract][Full Text] [Related]
9. The Negative Impact of Cancer Cell Nitric Oxide on Photodynamic Therapy.
Fahey JM; Girotti AW
Methods Mol Biol; 2022; 2451():21-31. PubMed ID: 35505007
[TBL] [Abstract][Full Text] [Related]
10. Role of nitric oxide in hyper-aggressiveness of tumor cells that survive various anti-cancer therapies.
Girotti AW; Fahey JF; Korytowski W
Crit Rev Oncol Hematol; 2022 Nov; 179():103805. PubMed ID: 36087851
[TBL] [Abstract][Full Text] [Related]
11. Cytoprotective induction of nitric oxide synthase in a cellular model of 5-aminolevulinic acid-based photodynamic therapy.
Bhowmick R; Girotti AW
Free Radic Biol Med; 2010 May; 48(10):1296-301. PubMed ID: 20138143
[TBL] [Abstract][Full Text] [Related]
12. Hyper-Aggressiveness of Bystander Cells in an Anti-Tumor Photodynamic Therapy Model: Role of Nitric Oxide Produced by Targeted Cells.
Bazak J; Korytowski W; Girotti AW
Crit Rev Oncog; 2023; 28(1):15-25. PubMed ID: 37824384
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of pro-tumor nitric oxide by anti-tumor photodynamic therapy.
Girotti AW; Fahey JM
Biochem Pharmacol; 2020 Jun; 176():113750. PubMed ID: 31836386
[TBL] [Abstract][Full Text] [Related]
14. Bystander effect in photosensitized prostate cancer cells with a different grade of malignancy: The role of nitric oxide.
Gani M; Xodo LE; Rapozzi V
Nitric Oxide; 2022 Nov; 128():25-36. PubMed ID: 35970264
[TBL] [Abstract][Full Text] [Related]
15. Signaling events in apoptotic photokilling of 5-aminolevulinic acid-treated tumor cells: inhibitory effects of nitric oxide.
Bhowmick R; Girotti AW
Free Radic Biol Med; 2009 Sep; 47(6):731-40. PubMed ID: 19524035
[TBL] [Abstract][Full Text] [Related]
16. Antagonistic Effects of Endogenous Nitric Oxide in a Glioblastoma Photodynamic Therapy Model.
Fahey JM; Emmer JV; Korytowski W; Hogg N; Girotti AW
Photochem Photobiol; 2016 Nov; 92(6):842-853. PubMed ID: 27608331
[TBL] [Abstract][Full Text] [Related]
17. Cytoprotective signaling associated with nitric oxide upregulation in tumor cells subjected to photodynamic therapy-like oxidative stress.
Bhowmick R; Girotti AW
Free Radic Biol Med; 2013 Apr; 57():39-48. PubMed ID: 23261943
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide antagonism to glioblastoma photodynamic therapy and mitigation thereof by BET bromodomain inhibitor JQ1.
Fahey JM; Stancill JS; Smith BC; Girotti AW
J Biol Chem; 2018 Apr; 293(14):5345-5359. PubMed ID: 29440272
[TBL] [Abstract][Full Text] [Related]
19. Bystander effects of nitric oxide in anti-tumor photodynamic therapy.
Bazak J; Fahey JM; Wawak K; Korytowski W; Girotti AW
Cancer Cell Microenviron; 2017; 4(1):. PubMed ID: 29201944
[TBL] [Abstract][Full Text] [Related]
20. Upstream signaling events leading to elevated production of pro-survival nitric oxide in photodynamically-challenged glioblastoma cells.
Fahey JM; Korytowski W; Girotti AW
Free Radic Biol Med; 2019 Jun; 137():37-45. PubMed ID: 30991141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
